(Q33630570)

28 July 2017

1 reference

title

Intermittent claudication in older patients. Practical treatment guidelines (English)

1 reference

intermittent claudication

28 July 2017

1 reference

1 reference

Boccalon H

1

1 reference

28 July 2017

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

14

1 reference

28 July 2017

4

1 reference

28 July 2017

247-259

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199914040-00002

28 July 2017

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease

1 reference

12 December 2020

Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS).

1 reference

12 December 2020

Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease

1 reference

12 December 2020

Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study

1 reference

12 December 2020

The effect of naftidrofuryl on intermittent claudication: a meta-analysis

1 reference

12 December 2020

Evaluation and management of patients with both peripheral vascular and coronary artery disease

1 reference

12 December 2020

Exercise training improves functional status in patients with peripheral arterial disease

1 reference

12 December 2020

The health risks of smoking. The Framingham Study: 34 years of follow-up.

1 reference

12 December 2020

Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

12 December 2020

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

1 reference

12 December 2020

Peripheral vascular disorders. A pharmacoeconomic and quality-of-life review

1 reference

12 December 2020

Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication.

1 reference

12 December 2020

Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders

1 reference

12 December 2020

Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Re

1 reference

12 December 2020

Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.

1 reference

12 December 2020

The pentoxifylline experience: exercise testing reconsidered

1 reference

12 December 2020

Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial

1 reference

12 December 2020

Quality of life following percutaneous transluminal angioplasty for claudication.

1 reference

12 December 2020

Building a partnership between vascular medicine and vascular surgery: a coalition for the future of vascular care

1 reference

12 December 2020

A review of the clinical effectiveness of exercise therapy for intermittent claudication

1 reference

12 December 2020

Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials

1 reference

12 December 2020

Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial

1 reference

12 December 2020

Intermittent claudication in 8343 men and 21-year specific mortality follow-up

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Conservative management of intermittent claudication

1 reference

12 December 2020

Double-blind placebo-controlled trial of buflomedil in intermittent claudication

1 reference

12 December 2020

Drugs in cerebral and peripheral arterial disease

1 reference

12 December 2020

1 reference

12 December 2020

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

12 December 2020

Pharmacological approaches to the treatment of intermittent claudication

1 reference

12 December 2020

Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program

1 reference

12 December 2020

Antithrombotic drugs in peripheral obliterative arterial diseases

1 reference

12 December 2020

1 reference

12 December 2020

Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication

1 reference

12 December 2020

Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study

1 reference

12 December 2020

Intermittent claudication: not so benign

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

1 reference

12 December 2020

The impact of intermittent claudication on quality of life evaluated by the Sickness Impact Profile technique.

1 reference

12 December 2020

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Peripheral vascular effects of beta-blockers

1 reference

12 December 2020

10.2165/00002512-199914040-00002

Identifiers

DOI

1 reference

PubMed ID

10319240

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10319240